NCT04490733 · RECRUITING
Developing Risk Prediction Model and Testing the Effect of Dual Task Walking on Improving Cognitive Function in Patients With Colorectal Cancer
This trial tests whether dual-task walking — walking while simultaneously doing a mental exercise — can help preserve or improve cognitive function in colorectal cancer patients. Researchers also want to build a model to predict who is at risk for cancer-related cognitive decline. This is a Phase NA behavioral study, meaning it is exploring an intervention approach rather than testing a drug.
You may qualify if
- Patients with newly diagnosed stage I to III colorectal cancer.
You're excluded if
- Patients with cancer other than colorectal cancer or have cancer recurrence.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-06-19